Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitris Skokos

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|January 30, 2013
Notch pathway activation targets AML-initiating cell homeostasis and differentiationCamille Lobry, Panagiotis Ntziachristos, Delphine Ndiaye-Lobry, et al.
JCI Insight|March 9, 2018
CD8+ T cells in beige adipogenesis and energy homeostasisMaria Moysidou, Sevasti Karaliota, Elisavet Kodela, et al.
Cell Reports|February 2, 2018
Delta-like Ligand-4-Notch Signaling Inhibition Regulates Pancreatic Islet Function and Insulin SecretionFabienne Billiard, Sevasti Karaliota, Bei Wang, et al.
Nature Cancer|June 6, 2022
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinomaNikos Kourtis, Qingqing Wang, Bei Wang, et al.
The Journal of Experimental Medicine|May 2, 2012
Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in miceFabienne Billiard, Camille Lobry, Guillaume Darrasse-Jèze, et al.
Science Immunology|November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Nature Communications|April 30, 2015
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturationMarianna Papaspyridonos, Irina Matei, Yujie Huang, et al.
Molecular Cancer Therapeutics|March 8, 2017
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human <i>PD-1</i> Knock-In MiceElena Burova, Aynur Hermann, Janelle Waite, et al.
Glycobiology|June 21, 2023
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement bindingSarah Y Ebstein, Ashique Rafique, Yi Zhou, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|January 30, 2013
Notch pathway activation targets AML-initiating cell homeostasis and differentiationCamille Lobry, Panagiotis Ntziachristos, Delphine Ndiaye-Lobry, et al.
JCI Insight|March 9, 2018
CD8+ T cells in beige adipogenesis and energy homeostasisMaria Moysidou, Sevasti Karaliota, Elisavet Kodela, et al.
Cell Reports|February 2, 2018
Delta-like Ligand-4-Notch Signaling Inhibition Regulates Pancreatic Islet Function and Insulin SecretionFabienne Billiard, Sevasti Karaliota, Bei Wang, et al.
Nature Cancer|June 6, 2022
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinomaNikos Kourtis, Qingqing Wang, Bei Wang, et al.
The Journal of Experimental Medicine|May 2, 2012
Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in miceFabienne Billiard, Camille Lobry, Guillaume Darrasse-Jèze, et al.
Science Immunology|November 4, 2018
<b>Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8</b>Bei Wang, Wen Zhang, Vladimir Jankovic, et al.
Nature Communications|April 30, 2015
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturationMarianna Papaspyridonos, Irina Matei, Yujie Huang, et al.
Molecular Cancer Therapeutics|March 8, 2017
Characterization of the Anti-PD-1 Antibody REGN2810 and Its Antitumor Activity in Human <i>PD-1</i> Knock-In MiceElena Burova, Aynur Hermann, Janelle Waite, et al.
Glycobiology|June 21, 2023
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement bindingSarah Y Ebstein, Ashique Rafique, Yi Zhou, et al.
Ebiomedicine|September 13, 2024
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19Bei Wang, Jacquelynn Golubov, Erin M Oswald, et al.
Pageof 4